Copernicus Capital Management as of March 31, 2021
Portfolio Holdings for Copernicus Capital Management
Copernicus Capital Management holds 14 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| BioMarin Pharmaceutical (BMRN) | 12.2 | $755k | 10k | 75.50 | |
| Regeneron Pharmaceuticals (REGN) | 11.5 | $710k | 1.5k | 473.33 | |
| Fate Therapeutics (FATE) | 10.7 | $660k | 8.0k | 82.50 | |
| Abbvie (ABBV) | 10.5 | $649k | 6.0k | 108.17 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 10.4 | $645k | 3.0k | 215.00 | |
| Revolution Medicines (RVMD) | 7.4 | $459k | 10k | 45.90 | |
| Rocket Pharmaceuticals (RCKT) | 5.7 | $355k | 8.0k | 44.38 | |
| Gritstone Oncology Ord (GRTS) | 5.6 | $349k | 37k | 9.43 | |
| Tg Therapeutics (TGTX) | 5.4 | $337k | 7.0k | 48.14 | |
| Ardelyx (ARDX) | 5.3 | $331k | 50k | 6.62 | |
| Arcus Biosciences Incorporated (RCUS) | 4.5 | $281k | 10k | 28.10 | |
| Atreca Cl A Com (BCEL) | 4.5 | $276k | 18k | 15.33 | |
| Teladoc (TDOC) | 4.4 | $273k | 1.5k | 182.00 | |
| Orchard Therapeutics Ads | 1.8 | $109k | 15k | 7.27 |
